| Heinze, Susanne: Triptorelinazetat 2,1 mg versus Triptorelinazetat 4,12 mg zur ovariellen Suppression im Rahmen der In-vitro-Fertilisation. Eine prospektive randomisierte Dosisfindungsstudie |
57
1. Abdalla, H., Baber, R., Leonard, T .: "Timed oocyte collection in an assisted conception program using GnRH analogue" . Hum Reprod 4 (1989 ) 927-930
2. Abdalla, H., Ahuja, T., Leonard, T., Morris, N., Honour, J., Jacobs, H .: "Comparative trial of lu-teinizing hormone-releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in an assisted conception program." Fertil Steril 53 (1990 ) 473-478
3. Aboulghar, M. A., Mansour, R. T., Serour, G. I., Amin, Y. M .: "The prognostic value of success-ful in-vitro fertilization in subsequent trials" . Hum Reprod 9 (1994 ) 1932-1934
4. Al-Hasani, S., Küpker, W., Felberbaum, R., Diedrich, C., Sturm, R., Bauer, O., Diedrich, K .: "Die intrazytoplasmatische Spermieninjektion unter Verwendung des Mini-Swim-Up-Verfahrens" . Fertilität 11 (1995 ) 111-114
5. Antoine, J., Salat-Baroux, J., Alvarez, S., Cornet, D., Tibi, C., Mandelbaum, J .: "Ovarian stimula-tion using human menopausal gonadotropin with or without LHRH analogues in a long protocol for in vitro fertilisation: a prospective randomised comparison." Hum Reprod 5 (1990 ) 565-569
6. Arimura, A .: "The backstage story of the discovery of LHRH" . Endocrinology 129 (1991 ) 1687-1689
7. Baird, D. T .: "A model for follicle selection and ovulation: lessons from superovulation" . J Steroid Biochem 27 (1987 ) 15-23
8. Balasch, J., Gomez, F., Casamitjana, R., Carmona, F., Rivera, F., Vanrell, J. A .: "Pituitary-ovarian suppression by the standard and half-doses of D-Trp-6-luteinizing hormone-releasing hormone depot." Hum Reprod 7 (1992 ) 1230-1234
9. Balasch, J., Manau, D., Mimo, J .: "Sequential gonadotrophin-releasing hormone agonist/low-dose oral contraceptive treatment for leiomyomata uteri." Hum Reprod 10 (1995 ) 529-532
10. Bettendorf, G., Lindner, C. : "Ovarielle Funktionsstörungen und deren Therapie." In: Bettendorf, G., Breckwoldt, H. (Hrsg.): Reproduktionsmedizin. Gustav Fischer Verlag, Stuttgart (1990 ), S. 427-463
58
11. Bonduelle, M., Legein J., Buysee, A., Devroey, P., van Steirteghem, A. C., Liebaers, I .: "Com-parative follow-up study of 130 children born after ICSI and 130 children born after IvF." Ab-stracts of the 10th Annual Meeting of the ESHRE, Brussels (1994 )12. Bouchard, P., Leroy, I., Christin-Maitre, S., Olivennes, F., Charbonnel, B., Frydman, R. : "Perspec-tives on the use of GnRH antagonists in ovulation induction." In: Filicori, M., Flamigni, C. (Hrsg.): Treatment with GnRH analogs: Controversies and perspectives. Parthenon Publishing Group , New York, London (1995 ), p. 195-199
13. Breckwoldt, M., Karck, U., Keck, C .: "Endokrinologie: Anatomie und Physiologie der weiblichen Geschlechtsorgane." In: Keck, C., Neulen, J., Breckwoldt, M. (Hrsg.): Praxis der Frauenheilkunde. Band I . Thieme, Stuttgart, New York (1997 ), S. 2-16
14. Broekmans, F. J ".: GnRH agonists and uterine leiomyomas" . Hum Reprod 11 , Suppl. 3 (1996 ) 3-25
15. Broekmans, F. J., Hompes, P. G. A., Lambalk, C.-B., Schoute, E., Broeders, A., Schoemaker, J. : "Short term pituitary desensitization: effects of different doses of the gonadotrophin-releasing hor-mone agonist triptorelin." Hum Reprod 11 (1996 ) 55-60
16. Buckett, W. M., Tan, S. L .: "Use of GnRH agonists in ovulation induction." In: Filicori, M., Flamigni, C. (Hrsg.): Treatment of infertility: the new frontiers. Communications Media for Education (1998 ), p. 135-138
17. Burgus, R., Butcher, M., Amoss, M. : "Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LFR)." Proc Natl Acad Sci USA 96 (1972 ) 278
18. Bühler, K. : "Safety aspects of the use of GnRH agonists in benign and malign indications." Gynecol Endocrinol 13, Suppl. 1 (1999 ) 48
19. Casper, R. F., Armstrong, D. T., Brown, S. E., Daniel, S. A., Yuzpe, A. A., Erskine, H. : "In vitro fertilization: determination of follicular maturation for timing of human chorionic gonadotropin administration." Fertil Steril 47 (1987 ) 345-349
20. Casper, R. F .: "Potential benefits of GnRH antagonists in assisted reproduction." Gynecol Endocrinol 13, Suppl. 1 (1999 ) 15
59
21. Check, J. H., Lurie, D., Callan, C., Baker, A., Benfer, K. : "Comparison of the cumulative prob-ability of pregnancy after in-vitro fertilization-embryo transfer by infertility factor and age." Fertil Steril 61 (1994 ) 257-26322. Cirkel, U .: "Medical treatment of symptomatic endometriosis." Hum Reprod 11, Suppl. 3 (1996 ) 89-102
23. Daya, S .: "The outcome of gonadotropin releasing hormone agonist (GnRHa) administration in early pregnancy." Gynecol Endocrinol 13, Suppl. 1 (1999 ) 49
24. Deutsches IvF-Register, Jahrbuch 1996
25. Deutsches IvF-Register, Jahrbuch 1997
26. Deutsches IvF-Register, Jahrbuch 1998
27. Devroey, P., Albano, C., Smitz, J., Felberbaum, R., Diedrich, K .: "New concepts in COS-ART related to the use of LHRH antagonists." Gynecol Endocrinol 13, Suppl. 1 (1999 ) 16
28. Diedrich, K .: "Neue Wege in Diagnostik und Therapie der Sterilität." Enke , Stuttgart (1990 )
29. Diedrich, K., Felberbaum, R., Baumann, P .: "Assistierte Reproduktion - Ein Überblick." Gynäkologe 29 (1996 ) 413-419
30. Edwards, R. G., Handyside, A. H .: "Future developments in IVF" . Br Med Bull 46 (3) (1990 ) 823-841
31. Elgendy, M., Afnan, M., Holder, R., Lashen, H., Afifi, Y., Lenton, W., Sharif, K .: "Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovar-ian response and in-vitro fertilization outcome." Hum Reprod 13 (1998 ) 2382-2385
32. Embryonenschutzgesetz: Annahme eines Gesetzesentwurfes durch den Deutschen Bundestag vom 10.10.1990 mit Gültigkeit ab dem 01.01.1991 (1990 )
33. Fauser, B .: "Endocrinological findings during treatment with Ganirelix (Orgalutran®)." Gynecol Endocrinol 13, Suppl. 1 (1999 ) 13
34. Felberbaum, R .: "New Lamps for old? - Agonists vs antagonists in ART." Gynecol Endocrinol 13, Suppl. 1 (1999 ) 23
60
35. Felberbaum, R., Diedrich, K .: "Klinischer Einsatz der GnRH Analoga im Rahmen der Sterilitäts-therapie: Agonisten und Antagonisten." Gynäkologe 29 (1996 ) 420-43236. Felberbaum, R. Diedrich, K .: "Use of GnRH antagonists in ovulation induction" . In: Filicori, M., Flamigni, C. (Hrsg.): Treatment of infertility: the new frontiers. Communications media for education (1998 ) p. 139-151
37. Feldberg, D., Dicker, D., Farhi, J., Shalev, J., Ashkenazi, J., Ben-Rafael, Z .: "Minidose gonad-otropin-releasing hormone agonist is the treatment of choice in poor responders with high folli-cle-stimulating hormone levels" . Fertil Steril 62 (1994 ) 343-346
38. Filicori, M., Hall, D., Loughin, J .: "A conservative approach to the management of uterine leio-myomata: pituitary desensitisation by a luteinizing hormone-releasing hormone analogue." Am J Obstet Gynecol 147 (1983 ) 726-729
39. Filicori, M., Cognini, G. E., Arnone, R., Falbo, A., Pocognoli, C., Tabarelli, C., Carbone, F., Ciampaglia, W., Pari, C., Casadio, P .: "Endocrine and clinical characteristics of different GnRH agonist regimens used for gonadotropin ovulation induction." In: Filicori, M., Flamigni, C. (Hrsg.): Treatment with GnRH analogs: Controversies and perspectives. Parthenon Publishing Group , New York, London (1995 ), p. 183-187
40. Filicori, M., Cognini, G. E., Arnone, R., Carbone, F., Falbo, A., Tabarelli, C., Ciampaglia, W., Casadio, P., Spettoli, D., Pecorari, R. : "Role of different GnRH agonists regimens in pituitary sup-pression and the outcome of controlled ovarian hyperstimulation." Hum Reprod 11, Suppl. 3 (1996 ) 123-132
41. FIVNAT: French national IVF registry: "analysis of 1986 to 1990 data" . Fertil Steril 59 (1993 ) 587-595
42. Fleming J., Haxton, M. J., Hamilton, M. P., McCune, G. S., Black, W. P., MacNaughton, M. C., Coutts, J. R .: "Successful treatment of infertile women with oligomenorrhoea using a combination of an LH-RH agonist and exogenous gonadotrophins." Br J Obstet Gynaecol 92 (1985 ) 369-373
43. Fleming, J., Coutts, J. R. T .: "Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression." Fertil Steril 45 (1986 ) 226-230
61
44. Ganirelix dose-finding study group : "A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarien stimulation with recombi-nant follicle stimulating hormone (Puregon ®)." Hum Reprod 13 (1998 ) 3023-303145. Gembruch, U., Diedrich, K., Al-Hasani, S., Welker, B., Wahode, J., van der Ven, H., Krebs, D. : "Transvaginale, ultraschall-kontrollierte Follikelpunktion." Geburtsh Frauenheilk 48 (1988 ) 617-624
46. Hillier, S. G .: "Roles of follicle stimulating hormone and luteinizing hormone in controlled ovar-ian hyperstimulation." Hum Reprod 11, Suppl. 3 (1996 ) 113-121
47. Hodgen, G. : "GnRH agonists and antagonists in ovarien stimulation." Hum Reprod 11, Suppl 1 (1996 ) 123-136
48. Hull, M. G. R .: "Indications for assisted conception." Br Med Bull 46 (1990 ) 580-595
49. Hull, M. G. R., Glazener, C., Kelly, N., Conway, D., Foster, P., Hinton, R., Coulson, C., Lambert, P., Watt, E., Desai, K .: "Population studies of causes, treatment and outcome of infertility." Br Med J 291 (1985 ) 1693-1697
50. Janssens, R., Lambalk, C., Vermeiden, J., Schats, R., Schoemaker, J., Mak, S. : "Dose-finding study of triptorelin acetate for prevention of premature LH surge: a prospektive, randomized, double-blind, placebo-controlled study." Hum Reprod 13, Abstract Book 1 (1998 ) 49-50
51. Jones, H. W. Jr. : "What has happened? Where are we? In: Human conception in-vitro." Hu m Reprod 11 (1996 ) 7-24
52. Karck, U .: GnRH und seine Analoga , Wissenschaftliche Verlagsgesellschaft , Stuttgart (1996 )
53. Kentenich, H .: "Die In Vitro Fertilisation im Rahmen einer Kinderwunschsprechstunde unter besonderer Berücksichtigung psychosozialer Gesichtspunkte." Habilitationsschrift , vorgelegt am Fachbereich 3 -UKRV- der Freien Universität Berlin (1989 )
54. Kentenich, H. : "Männliche Subfertilität als limitierender Faktor" . Alete Wissenschaftlicher Dienst , Jubiläumsveranstaltung der Gesellschaft für Geburtshilfe und Gynäkologie in Berlin, 12.-14. Mai 1994 (1994 )
62
55. Kentenich, H., Pachaly, J., Schmiady, H., Schönegg, W., Radke, E., Dincer, C., Stauber, M .: "Prognostischer Wert von Spermiogrammparametern für den IVF-Erfolg." F ertilitä t 3 (1987 ) 151-15656. Kentenich, H., Sabri, O., Schmiady, H., Schönegg, W., Stauber, M .: "Lohnt es sich, kleinere Follikel zu punktieren? Zur Abhängigkeit von Follikelgröße und Teilungsrate." In: Schirren, C., Semm, K. (Hrsg.): Fortschritte der Fertilitätsforschung , Band 16 . Grosse , Berlin (1988 ), S . 270
57. Kentenich, H., Würfel, W. : "IvF bei ungewollter Kinderlosigkeit. Ein Weg mit Chancen." Informationsbroschüre der Kinderwunschsprechstunde der DRK-Frauenklinik, Pulsstraße. Organon GmbH (Hrsg.), Oberschleißheim (1996 )
58. Kerin, J. F., Warnes, G. M. : "Monitoring of ovarian response to stimulation in in-vitro fertilization cycles" . Clin Obstet Gynecol 29 (1986 ) 158-170
59. Kingsland, C., Tan, S., Bickerton, N., Mason, B., Campbell, S. : "The routine use of gonadotropin-releasing hormone agonists for all patients undergoing in vitro fertilisation. Is there any medical advantage? A prospective randomized study." Fertil Steril 57 (1992 ) 804-809
60. Kubic, C., Guzick, D., Berga, S., Zeleznik, A. : "Randomized, prospective trial of leuprolide ace-tate and conventional superovulation in first cycles of in vitro fertilisation and gamete intrafallo-pian transfer." Fertil Steril 54 (1990 ) 836-841
61. Küpker, W., Al-Hasani, S., Bauer, O., Diedrich, K. : "Neue Techniken der assistierten Befruchtung. " Fertilität 10 (1994 ) 216-220
62. Labrie, F .: "GnRH agonists in prostate cancer." In: Lunenfeld, B.,Insler, V. (Hrsg.): GnRH ana-logues: State of the art, Parthenon Publishing Group , New York, London (1993 ), p. 103-122
63. Lehmann, F., Diedrich,K, van der Ven, H., Al-Hasani, S., Hamerich, U., Krebs, D .: "Die Durchführung der laparoskopischen Follikelpunktion und Eizellgewinnung zur in vitro Fertilisation." Geburtsh Frauenheilk 44 (1984 ) 388-391
64. Leidenberger, F. A., Ahrendt, H.-J., Bamberger, A.-M., Brill, K., Cirkel, U., Elger, W., Höppner, W., Huber, J., Luderschmidt, Ch., Moltz, L., Mukhopadhyay, A., Naether, O. G. J., Rudolf, K., Schulte, H. M., Schulze, W., Stahnke, N., Teichmann, A. T., Tinneberg, H. R., Weise, H.-Ch .: Klinische Endokrinologie für Frauenärzte , 2. Aufl., Springer Verlag (1998 )
63
65. Lewit, N., Kol, S., Manor, D., Itskovitz-Eldor, J. : "The use of GnRH analogs for induction of the preovulatory gonadotropin surge in assisted reproduction and prevention of the ovulatory hyper-stimulation syndrome" . Gynecol Endocrinol 9, Suppl. 4 (1995 ) 13-1866. Leyendecker, G., Wildt, L., Hansmann, M .: "Pregnancies following chronic intermittent (pulsa-tile) administration of GnRH by means of protable pump (Zyklomat) - A new approach of the treatment of infertility in hypothalmic amenorrhea." J Clin Endocrinol 51 (1980 ) 1214-1216
67. Lindner, C., Braendle, W., Lichtenberg, V .: "Ovarian response and pregnancy rates in In Vitro fertilization, gamete intrafallopian transfer, and in In Vitro fertilization therapies after combined gonadotropin-releasing hormone agonist/human menopausal gonadotropin stimulation." Gynecol Obstet Invest 29 (1990 ) 140
68. MacLachlan, V., Besanko, M., O'Shea, F., Wade, H., Wood, C., Trounson, A., Healy, D .: "A con-trolled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilisation" . N Engl J Med 320 (1989 ) 1233-1237
69. Maheux, R .: "GnRH agonists: an alternative to surgery?" Hum Reprod 11, Suppl. 3 (1996 ) 43-50
70. Maheux, R., Gilloteau, C., Lemay, A. : "Luteinizing hormone-releasing hormoen agonists and uterine leiomyoma: a pilot study." Am J Obstet Gynecol 152 (1985 ) 1034-1038
71. Maheux, R., Lemay, A., Blanchet, P .: "Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing hormone-releasing hormone agonist implant: a pilot study." Hum Reprod 6 (1991 ) 500-505
72. Mannaerts, B., Oberyé, J., Peters, M., Orlemans, E .: "Introducing the new GnRH antagonist Ganirelix (Orgalutran®)." Gynecol Endocrinol 13, Suppl. 1 (1999 ) 12
73. Marcus, S., Edwards, E .: "High rates of pregnancy after long-term down-regulation of women with severe endometriosis." Am J Obstet Gynecol 171 (1994 ) 812-817
74. Maroulis, G., Emery, M., Verkauf, B., Saphier, A., Bernhisel, M., Yeko, T .: "Prospective randomized study of human menotropin versus a follicular and a luteal phase gonadotropin-releasing hormone analog - human menotropin stimulation protocols for in vitro fertilisation." Fertil Steril 55 (1991 ) 1157-1164
64
75. Martin, M., Gives, C., Schriock, E., Glass, R., Dandekar, P .: "The choice of a gonadotropin-releasing hormone analog influences outcome of in vitro fertilization treatment." Am J Obstet Gynecol 170 (1994 ) 1629-163476. Matsuo, H., Baba, Y., Nair, R., Arimura, A. Schally, A. : "Structure of porcine LH and FSH releas-ing factor. I. The proposed amino acid sequence" . Biochem Biophys Res Commun 43 (1971 ) 1334
77. Matta W. H., Shaw, R. W., Burford, G. D .: "Endocrinology and clinical evaluation following a single administration of a gonadotropin-releasing hormone agonist (Zoladex), in a depot formulation, to premenopausal women." Fertil Steril 49 (1988 ) 163-165
78. Meldrum, D. R., Chang, R. J., Lu, J., Vale, W., Rivier, J., Judd, H. L .: "Medical oophorectomy using a long-acting GnRH agonist - a possible new approach to the treatment of endometriosis." J Clin Endocrinol Metab 54 (1982 ) 1081-1083
79. Michelmann, H. W., Tinneberg, H. R., Weisner, D., Mettler, L. : "Die transvaginale ultraschallkontrollierte Follikelpunktion im Rahmen der menschlichen in vitro Fertilisation." Geburtsh Frauenheilk 47 (1987 ) 619-622
80. Naether, O. G. J., Baukloh, V., Fischer, R. : "Einfluss andrologischer Parameter auf den Ausgang der in-vitro-Fertilisation (IvF) - Verdoppelung der andrologischen Indikation innerhalb von 6 Jahren." Fertilität 11 (1995 ) 107-110
81. Nakamura, K., Oosawa, M., Kondou, I., Inagaki, S., Shibata, H., Narita, O., Suganuma, N., To-mody, Y .: "Menotropin stimulation after prolonged gonadotropin releasing hormone agonist pretreatment for in vitro fertilisation in patients with endometriosis." J Assist Reprod Genet 92 (1992 ) 113-117
82. Neulen, J .: "Reproduktionsmedizin; Rationelle Therapie der weiblichen Sterilität." In: Keck, C., Neulen, J., Breckwoldt, M. (Hrsg.): Praxis der Frauenheilkunde , Band I . Thieme , Stuttgart, New York (1997 ), S. 124-148
83. Neveu, S., Hedon, B., Bringer, J., Chinchole, J. M., Arnal, F., Hurneau, C., Cristol, P., Viala, J. L .: "Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization." Fertil Steril 47 (1987 ) 639-643
65
84. Olivennes, F., Belaisch-Allart, J., Emperaire, J. C., Hedon, B., Alvarez, S., Moreau, L., Nicollet, B., Zorn, J. R., Bouchard, P., Frydman, R. : "Comparison in a prospective multicentric randomized study in IVF-ET of a single dose of GnRH antagonist (Cetrorelix) to a GnRH agonist long proto-col (Triptoreline in depot formula)." Gynecol Endocrinol 13, Suppl. 1 (1999 ) 1485. Porcu, E., Dal Prato, L., Seracchioli, R., Fabbri, R., Petracchi, S., Flamigni, C. : "GnRH agonists and assisted reproduction outcome." In: Filicori, M., Flamigni, C. (Hrsg.): Treatment with GnRH analogs: Controversies and perspectives . Parthenon Publishing Group , New York, London (1995 ), p. 189-194
86. Porter, R. N., Smith, W., Craft, I. L., Abdulwahid, N. A., Jacob, H. S ".: Induction of ovulation for in-vitro fertilization using buserelin and gonadotropins." Lancet 2 (1984 ) 1284-1285
87. Radowicki, S., Koczorowski, R., Olszewska, D .: "Bone mass density (BMD) after 12 month treatment with aGnRH." Gynecol Endocrinol 13, Suppl. 1 (1999 ) 59
88. Radowicki, S., Koczorowski, R., Skórzewska, K. : "Hormonal profile women treated with Trip-torelin" . Gynecol Endocrinol 13, Suppl. 1 (1999 ) 59
89. Rietmüller-Winzen, H., Siebert-Weigel, M., Prothmann, A ".: Safety aspects of GnRH antagonists." Gynecol Endocrinol 13, Suppl. 1 (1999 ) 50
90. Rivier, J., Jiang, G.-C., Lahrichi, S. L., Porter, J., Koerber, S. C., Rizo, J., Corrigan, A., Gierasch, L., Hagler, A., Vale, W., Rivier, C. : "Dose relationship between GnRH-antagonists and pituitary suppression." Hum Reprod 11, Suppl. 3 (1996 ) 133-147
91. Ron-El, R., Herman, A., Golan, A., Nachum, H., Soffer, Y., Caspi, E .: "Gonadotropins and com-bined gonadotropins protocols in a randomized prospective study." Fertil Steril 55 (1991 ) 574-578
92. Runnebaum, B., Breckwoldt, M. : Leuprorelinacetat - Ein neues GnRH-Analogon. Grundlagen und Klinik, Springer-Verlag Berlin, Heidelberg (1992 )
93. Rutherford, A .: "Improvement on in-vitro fertilization after treatment with buserelin, an agonist of luteinizing hormone releasing hormone." Br Med J 296 (1988 ) 1965-1968
94. Rutherford, A., Subak-Sharpe, R., Dawson, K., Margara, R., Franks, S., Winston, R. : "Improvement of in vitro fertilization after treatment with buserelin, an agonist of luteinizing hormone r-leasing hormone." Br Med J 296 (1988 ) 1765-1768
66
95. Samuel, F. M., Brinsden, P. R., Macnamee, M., Rainsbury, P. A., Elder, K. T., Edwards, R. G. : "Comparative trial between an ultra-short and long protocol of luteinizing hormone-releasing hormone agonist for ovarian stimulation in in-vitro fertilization." Hum Reprod 3 (1993 ) 238-24396. Schoemaker, J., Scheele, F., Broekmans, F. J. M., Janssens, M. J .: "GnRH analogs in in vitro fertilization: to dose or overdose? " Gynecol Endocrinol 9, Suppl. 4 (1995 ) 3-6
97. Seifert, B., Hein, H., Käsbauer, J., Libl, A., Seifert, D. : "Der Effekt wiederholter Down-Regulationen mit Decapetyl-Depot auf die klinischen Behandlungsergebnisse der IVF-ET während 3 Zyklen." Fertilität 13 (1998 ) 206-211
98. Siler-Khodr, T. M. : "GnRH agonist and the trophoblast and embryo." Gynecol Endocrinol 13, Suppl. 1 (1999 ) 49
99. Simon, A., Benshushan, A., Shushan, A., Zajicek, G., Dorembus, D., Lewin, A, Laufer, N. : "A comparison between a standard and reduced dose of D-Trp-6-luteinizing hormone-releasing hor-mone administered after pituitary suppression for in-vitro fertilization." Hum Reprod 9 (1994 ) 1813-1817
100. Smitz, J., Devroey, P., Braeckman, P. : "Management of failed cycles in a IVF/GIFT programme with the combination of a GnRH analogue and HMG." Hum Reprod 2 (1987 ) 309-314
101. Society for Assisted Reproductive Technology (SART): "Assisted reproducitve technology in the United States and Canada: 1992 results generated from the American Fertility Society/Society for Assisted Reproductive Technology Registry." Fertil Steril 59 (1993 ) 1239-1244
102. Society for Assisted Reproductive Technology (SART): "Assisted reproducitve technology in the United States: 1996 results generated from the American Fertility Society/Society for Assisted Reproductive Technology Registry." Fertil Steril 71 (1999 ) 798-807
103. Steptoe, P. C., Edwards, R. G .: "Birth after the reimplantation of a human embryo." Lancet 2 (1978 ) 366
104. Tan, S. L. : "Use of oral contraceptive and LHRH agonist for patient scheduling in ART." Gynecol Endocrinol 13, Suppl. 1 (1999 ) 21
67
105. Tarlatzis, B., Mannaerts, B. : "Clinical outcome of a multi-center trial of Ganirelix (Orgalutran®) in women undergoing controlled ovarien hyperstimulation." Gynecol Endocrinol 13, Suppl. 1 (1999 ) 13106. Tsai, H.-D., Chen, C. M., Lo, H. Y., Chang, C. C. : "Subcutaneous low dose leuprolide acetate depot versus leuprolide acetate for women undergoing ovarian stimulation for in-vitro fertilization." Hum Reprod 10 (1995 ) 2909 - 2912
107. Tuckey, J. W .: Exploratory data analysis. Addison-Wesley Publishing Company , Reading, Massachusetts (1977 )
108. van der Ven, H. : "Neue Aspekte der Inseminationsbehandlung." In: Diedrich, K. (Hrsg.): Neue Wege in Diagnostik und Therapie der weiblichen Sterilität. Enke , Stuttgart (1987 ) S. 104
109. van der Ven, Runnebaum, Diedrich, Vogt, Geisthövel, Würfel, Michelmann : "Stellungnahme der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe und der Arbeitsgemeinschaft für gynäkologische Endokrinologie und Fortpflanzungsmedizin: Empfehlungen zur Durchführung der intrazytoplasmatischen Spermieninjektion (ICSI) als Zusatzmaßnahme bei IVF-ET-Therapie." Frauenarzt 36 (6) (1995 ) 618-619
110. van Steirteghem, A. C., Liu, J., Joris, H., Nagy, Z., Janssenswillen, C., Tournaye, H., Derde, M. P., van Assche, E., Devroey, P.: "Higher success rate by intracytoplasmasmic sperm injection than by subzonal insemination. Report of a second series of 300 consecutive treatment cycles." Hum Reprod 8 (1993 ) 1055-1060
111. Vargyas, J. M., Morente, C., Shangold, G., Marrs, R. P. : "The effect of different methods of ovar-ian stimulation for in vitro fertilization and embryo transfer replacement." Fertil Steril 42 (1984 ) 745-749
112. Verteilungsfreie Vertrauensgrenzen für Quantile stetiger Verteilungen. In: Wiss. Tabellen Geigy. Teilband Statistik. 8. Auflage. Ciba-Geigy-AG Basel (1980 ), S. 103 und 198
113. Watanabe, Y., Nozaki, M., Nakamura, G.-I., Sano, M., Matsuguchi, H., Nakano, H. : "Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women." Fertil Steril 58 (1992 ) 66-71
68
114. Wildt, L., Diedrich, K., van der Ven, H.: "Ovarian hyperstimulation for in vitro fertilization con-trolled by GnRH agonist administered in combination with human menopausal gonadotrophins. " Hum Reprod 1 (1986 ) 15-19115. Yuzpe, A. A., Nisker, J. A., Kaplan, B. R., Tummon, I. S., Auckland, J. : "Nafarelin acetate for pituitary down-regulation in in-vitro fertilization: Comparison of two dosages." J Reprod Med 40 (1995 ) 83-88
116. Zorn, J.-R., Barata, M., Brami, C., Epelboin, S., Nathan, C., Papageorgiou, G., Quantin, P., Rolet, F., Savale, M., Boyer, P., Guichard, A., Cedard, L., Comaru-Schally, A., Schally, A.: "Ovarian stimulation for in vitro fertilization combining administration gonadotrophins and blockade of the pituitary with D-Trp6-LHRH microcapsules: pilot studies with two protocols." Hum Reprod 3 (1988 ) 235-239
© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
|
DiML DTD Version 2.0 |
Zertifizierter Dokumentenserver der Humboldt-Universität zu Berlin |
HTML - Version erstellt am: Fri Nov 1 14:43:14 2002 |